Subsequent litigation, including challenges under the Hatch-Waxman Paragraph IV filing framework, ultimately shortened the exclusivity window, but the strategy generated substantial additional revenue during the contested period
Mistake 5: not adjusting timing during dose escalation You have been happily injecting at 7am every Thursday for 8 weeks
Drug Interactions In Vitro Assessment of Drug Interactions Sitagliptin is not an inhibitor of CYP isozymes CYP3A4, 2C8, 2C9, 2D6, 1A2, 2C19 or 2B6, and is not an inducer of CYP3A4
One subject randomized to liraglutide 1.2 mg had antibodies that crossreacted to GLP-1 in vitro at the end of the trial (the subject was exposed to both liraglutide 2.4 and 3.0 mg during the extension period)
If you stop GLP-1 medications like tirzepatide, research shows several common outcomes: Appetite increases Calories consumed gradually rise Weight regains within weeks to months Blood sugar improvements may diminish This is not a sign of failure, its simply biology
Wash thoroughly with soap and water, then dry with a clean towel
